2m 2m 2m 2m 2m 2m 2m
MANNKIND (MNKD)
NASDAQ
$3.21+$0.16 (+5.25%)
Price as of Oct 22, 2026 7:40 PM EDT- $980.7MMarket Cap
- -44.85%1-Year Change
- BiotechnologyIndustry
MANNKIND (MNKD)
$3.21+$0.16 (+5.25%)
MNKD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.05 | ||
Change | -$0.05 (-1.61%) | ||
Open | $3.10 | ||
High | $3.13 | ||
Low | $3.04 | ||
Previous Close | $3.10 | ||
Volume | 2,798,921 | ||
30-Day Average Volume | 5,258,291 | ||
1-Week Change | 0.99% | ||
1-Month Change | -12.86% | ||
1-Year Change | -44.85% | ||
3-Year Change | -27.55% | ||
5-Year Change | -30.84% | ||
Fundamentals | |||
Shares Outstanding | 321.5M | ||
Total Assets | $732.3M | ||
Market Cap | $980.7M | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $42.0M | ||
Net Income | -$19.0M | ||
Free Cash Flow | -$23.5M | ||
EBIT | -$4.3M | ||
EBITDA | $2.1M | ||
Net Working Capital | $102.8M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | 617 | ||
Enterprise Value/Revenue | 31 | ||
P/B | -15 | ||
P/E | -51 | ||
PEG | 3 | ||
Price/Free Cash Flow | -42 | ||
Price/Operating Cash Flow | -53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 03/03/2017 | ||
Earnings & Revenue